Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001714899-23-000123

President and CEO sold 2,526 shares at $25.03 ($63,226)

  • President and CEO acquired 2,526 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Watts Ryan J. President and CEO 2023-08-10 Option exercise +2,526 $0.68 $1,718 2,242,439 I: show line 1 in the form
Watts Ryan J. President and CEO 2023-08-10 Sale −2,526 $25.03 $63,226 2,239,913 I: show line 2 in the form
Open-market sales · 2,526 sh · avg $25.03 · $63,226

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Watts Ryan J. President and CEO 2023-08-10 Option exercise · Stock Option (right to buy) −2,526 1,118,091 D: show line 3 in the form
Loading xslF345X05/wk-form4_1692047595.xml…